ROCKVILLE, Md., Feb. 10 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. announced today that its presentation at the Biotechnology Industry Organization’s BIO CEO + Investor Conference will be webcast and may be accessed at http://www.hgsi.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )
A member of Human Genome Sciences’ senior management team will present an overview of the company on Wednesday, February 15, 2006 at 2:30 pm Eastern Time.
Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
Human Genome Sciences is a company with the mission to discover, develop, manufacture and market innovative drugs that serve patients with unmet medical needs, with a primary focus on protein and antibody drugs.
HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at http://www.hgsi.com.
Photo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk photodesk@prnewswire.comHuman Genome Sciences, Inc.
CONTACT: Jerry Parrott, Vice President, Corporate Communications,+1-301-315-2777, or Kate de Santis, Director, Investor Relations,+1-301-251-6003, both of Human Genome Sciences, Inc.
Web site: http://www.hgsi.com///
Company News On-Call: http://www.prnewswire.com/comp/121115.html/
